Table 3.
Laboratory findings between Rowachol and placebo groups at 3 months postoperatively
| Rowachol (n = 64) | Placebo (n = 63) | P | |
|---|---|---|---|
| Total bilirubin (mg/dL) | 0.7 ± 0.5 | 0.6 ± 0.2 | 0.43 |
| Direct bilirubin (mg/dL) | 0.3 ± 0.3 | 0.2 ± 0.2 | 0.40 |
| Alkaline phosphatase (IU/L) | 242.8 ± 449.8 | 209.6 ± 145.5 | 0.670 |
| Aspartate aminotransferase (IU/L) | 105.1 ± 60.5 | 50.8 ± 41.2 | 0.33 |
| Alanine aminotransferase (IU/L) | 44.3 ± 43.8 | 56.1 ± 49.1 | 0.35 |
| White blood cells (× 106/μl) | 6.8 ± 2.1 | 7.2 ± 2.4 | 0.38 |
Values denote mean ± standard deviation.